HomeCHM • ASX
add
Chimeric Therapeutics Ltd
Nakaraang pagsara
$0.0050
Sakop ng araw
$0.0050 - $0.0050
Sakop ng taon
$0.0038 - $0.031
Market cap
11.34M AUD
Average na Volume
2.28M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.78M | -49.37% |
Gastos sa pagpapatakbo | 4.11M | -10.84% |
Net na kita | -1.43M | -216.94% |
Net profit margin | -51.46 | -330.97% |
Kita sa bawat share | — | — |
EBITDA | -1.09M | -196.88% |
Aktuwal na % ng binabayarang buwis | -5.07% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 5.07M | 43.76% |
Kabuuang asset | 18.68M | -30.02% |
Kabuuang sagutin | 12.74M | -0.69% |
Kabuuang equity | 5.94M | — |
Natitirang share | 1.58B | — |
Presyo para makapag-book | ∞ | — |
Return on assets | -17.81% | — |
Return on capital | -55.99% | — |
Cash Flow
Net change in cash
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.43M | -216.94% |
Cash mula sa mga operasyon | -1.32M | 43.40% |
Cash mula sa pag-invest | 12.97K | 10.74% |
Cash mula sa financing | 2.29M | -21.82% |
Net change in cash | 1.01M | 73.30% |
Malayang cash flow | -264.26K | -134.62% |
Tungkol
Itinatag
2020
Website
